Daniel A. Laheru
Impact in
- Oncology top 0.05%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- CAR-T cell therapy research
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 149
- Pancreatic and Hepatic Oncology Research 122
- Cancer Immunotherapy and Biomarkers 22
- Colorectal Cancer Treatments and Studies 11
-
- Cancer Genomics and Diagnostics 28
- Co-authors
- Elizabeth M. Jaffee (36 shared papers)Ralph H. Hruban (51 shared papers)Joseph M. Herman (72 shared papers)Christopher Lee Wolfgang (49 shared papers)Eric R. Lutz (9 shared papers)Mark M. Yarchoan (12 shared papers)Manuel M. Hidalgo (29 shared papers)Lei Zheng (48 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (20 papers)Clinical Cancer Research (19 papers)Journal of Clinical Oncology (12 papers)Annals of Surgical Oncology (12 papers)Journal of Gastrointestinal Surgery (7 papers)
- Partner nations
- United StatesSpainCanada
In The Last Decade
Daniel A. Laheru
203 papers receiving 28.4k citations
Daniel A. Laheru's Hit Papers
Peers
Comparison fields: 5 of 153
- Oncology 18.5k
- Cancer Research 7.6k
- Immunology 3.8k
- Pulmonary and Respiratory Medicine 4.5k
- Biotechnology 1.1k
Countries citing papers authored by Daniel A. Laheru
This map shows the geographic impact of Daniel A. Laheru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Laheru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Laheru more than expected).
Fields of papers citing papers by Daniel A. Laheru
This network shows the impact of papers produced by Daniel A. Laheru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Laheru. The network helps show where Daniel A. Laheru may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel A. Laheru, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 212 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine Hit paper breakdown → | 2013 | 5355 |
| 2 | Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies Hit paper breakdown → | 2014 | 4133 |
| 3 | Gemcitabine Plus nab -Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial Hit paper breakdown → | 2011 | 914 |
| 4 | DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer Hit paper breakdown → | 2009 | 905 |
| 5 | Targeting neoantigens to augment antitumour immunity Hit paper breakdown → | 2017 | 815 |
| 6 | Recent progress in pancreatic cancer Hit paper breakdown → | 2013 | 735 |
| 7 | Safety and Survival With GVAX Pancreas Prime and Listeria Monocytogenes –Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer Hit paper breakdown → | 2015 | 529 |
| 8 | 2001 | 503 | |
| 9 | 2013 | 477 | |
| 10 | 2014 | 457 | |
| 11 | PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers Hit paper breakdown → | 2019 | 453 |
| 12 | Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors Hit paper breakdown → | 2012 | 432 |
| 13 | 2014 | 415 | |
| 14 | 2010 | 371 | |
| 15 | 2014 | 348 | |
| 16 | 2018 | 324 | |
| 17 | 2011 | 322 | |
| 18 | 2009 | 311 | |
| 19 | 2008 | 300 | |
| 20 | 2004 | 277 |
About Daniel A. Laheru
Daniel A. Laheru is a scholar working on Oncology, Cancer Research, Immunology, Epidemiology and Pulmonary and Respiratory Medicine, having authored 212 papers that have together received 29.0k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (122 papers), Cancer Genomics and Diagnostics (28 papers), Cancer Immunotherapy and Biomarkers (22 papers), Neuroendocrine Tumor Research Advances (16 papers), Immunotherapy and Immune Responses (13 papers), Colorectal Cancer Treatments and Studies (11 papers), Renal cell carcinoma treatment (9 papers) and Pancreatitis Pathology and Treatment (7 papers). The work is most often cited by research in Oncology (18.5k citations), Cancer Research (7.6k citations), Immunology (3.8k citations), Pulmonary and Respiratory Medicine (4.5k citations) and Biotechnology (1.1k citations). Daniel A. Laheru has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Elizabeth M. Jaffee, Ralph H. Hruban, Joseph M. Herman, Christopher Lee Wolfgang, Eric R. Lutz, Mark M. Yarchoan, Manuel M. Hidalgo, Lei Zheng, John L. Cameron and Alison Patricia Klein. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Clinical Cancer Research, Journal of Clinical Oncology, Annals of Surgical Oncology and Journal of Gastrointestinal Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.